BioMEMS Market size - Industry Analysis, Market Size, Share, Trends, Growth And Forecast 2024-2030.
BioMEMS Market Overview
The Global BioMEMS Market size is forecast to reach $24.5 billion by 2030, growing at a CAGR of 12.3% over the forecast period of 2024-2030. Growing technological advancement in biomedical research, medical micro-devices, biomedicine and others have been eventually driving the need for Biological Micro-Electro-Mechanical Systems (BioMEMS) market. Rising demand for BioMEMS devices applying traditional micro fabrication and microfluidics technology utilizing micro-sensors, actuators, transducers, and electronic components are some of the prime factors driving the global BioMEMS market. Furthermore, with growing adoption of micro total analysis system as a part of automating all biochemical analysis while ensuring optimization of diagnostic and therapeutic applications, BioMEMS devices has gained a huge traction. Growing incorporation of biomolecules as an integral part of the device is augmenting the market. Increasing proliferation of advanced genomics, proteomics and other biotechnology techniques is analyzed to create significant growth opportunities for BioMEMS market in the future years.
A significant trend in the BioMEMS market is the rising adoption of implantable devices designed for real-time health monitoring. This trend is driven by continuous technological advancements, focusing on bioMEMS implants that can monitor diverse physiological parameters within the body. These advanced implants integrate cutting-edge sensors, enabling continuous monitoring of crucial health metrics such as glucose levels, blood pressure, and vital signs. This trend aligns with the growing demand for personalized healthcare solutions, providing healthcare professionals with real-time data for enhanced diagnosis and more effective treatment planning. The integration of advanced monitoring into implantable devices signifies a shift towards tailored healthcare interventions, improving patient care.
Market Snapshot:
BioMEMS Market Report Coverage
The report: “BioMEMS Industry Outlook – Forecast (2024-2030)”, by IndustryARC covers an in-depth analysis of the following segments of the BioMEMS industry.
By Type – MEMS Sensors, Micro fluids, Others.
By Material -Silicon and Glass, Plastics and Polymers, Paper, Biological Material.
By Product – Injectables, Implantables (stents, gyroscopes, accelerometers, biochips, biosensors and drug delivery devices), Others.
By Application – Therapeutic, Tissue Engineering, Diagnostic, Others.
By End User -Home diagnostics, healthcare, pharmaceutical, research centers, agriculture, food, others.
By Geography - North America (U.S, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Others), APAC (China, Japan India, South Korea, Australia and Others), South America (Brazil, Argentina and others), and RoW (Middle east and Africa).
Key Takeaways
- BioMEMS sensor is analyzed to witness highest growth in the BioMEMS Market over the forecast period of 2024-2030 owing to growing integration of MEMS sensors with medical devices.
- North America BioMEMS Market held the largest share in 2023, attributing to factors like early adoption of IoT in medical research and high investments towards advanced technology in biomedical research, medical micro-devices, biomedicine and others.
- Increasing penetration of wearable medical devices among the geriatric population to improve remote diagnostics and monitoring along with growing integration of nanotechnology with Bio-MEMS supporting cellular interaction at molecular level are analyzed to significantly drive the global BioMEMS Market over the forecast period of 2024-2030.
For more details on this report - Request for Sample
BioMEMS Segment Analysis- By Type
By type, global BioMEMS Market has been segmented into MEMS Sensors, Microfuids, Others. Sensors is analyzed to grow with the highest CAGR of 42.8% during the forecast period 2024-2030. Integration of bioMEMS sensors with medical devices with an aim to optimize next-generation sequencing (NGS), drug delivery systems, Point-of-Care diagnostics and precision micro tools capabilities are one of the prime factors boosting the market growth over time. BioMEMS sensors aids in developing high throughput screening methods in order to detect biological components with maximized precision. In 2023, Vivalink's U.S. healthcare survey reported a substantial 305% increase, with 81% of clinicians utilizing Remote Patient Monitoring (RPM). An additional 84% of respondents using RPM plan to enhance their usage in 2024. This surge indicates a notable IoT adoption in healthcare, where sensors crucially enable real-time monitoring, contributing to RPM's effectiveness and IoT's expansion. In June 2023, Dynamic42 GmbH secured a mid-seven-figure financing round, attracting investment from bm-t and a health sector family office. The funds aimed to fuel the company's growth, expand globally, and enhance its technology platform. Dynamic42 specializes in organ-on-chip models for drug testing, offering a unique and flexible solution to increase the efficacy of detection in biological components for diagnostics purposes. Such factors are further set to propel the market growth of global BioMEMS Market in the long run.
BioMEMS Segment Analysis- By End Users
By end users, BioMEMS Market has been segmented into home diagnostics, healthcare, pharmaceutical, research centers, agriculture, food and others. Pharmaceutical sector dominated the global BioMEMS Market in 2023, and is analyzed to have a significant growth during 2024-2030. Rising shifts towards microfabricated platforms incorporated with BioMEMS and nanofabricated devices along with the growth in biomedicine is likely to continue in coming years, which in turn will increase the demand for BioMEMS devices. Growing adoption of BioMEMS devices in pharmaceutical sector to optimize the efficacy of therapeutics by integrating technologies like targeted drug delivery, timed drug release, and triggered drug release is resulting in speedy expansion of the market. In January 2024, Dr. Chao Ma's groundbreaking work on "Leukemia-on-a-Chip" for CAR T cell therapy demonstrated significant advancements. The utilization of 3D microfluidics-based technology offered a precise evaluation of CAR T cell therapy, expanding from conventional chemotherapy to novel therapeutics. The integration of single-cell mRNA sequencing enhanced the system's capabilities, validating cellular similarities and mapping molecular changes. This may contribute to increased usage of MEMS and microfluidics in cancer therapy research. Such factors will fuel the growth of BioMEMS market in coming years.
BioMEMS Segment Analysis- By Geography
By Geography, BioMEMS Market has been segmented into North America, Europe, APAC, South America and Others. North America dominated the global BioMEMS Market in 2023, owing to huge investments in healthcare sector and medical research. Rising investment towards innovative therapeutics or growth in biopharma industry is one of the key factors driving its market growth within the region. Factors such as rising disease awareness, well established health infrastructure, high investment towards domestic manufacturing of medical devices are the key factors fostering BioMEMS market in this region.
In September 2022, The White House announced federal funding of more than $2 billion to enable the U.S. to harness the full potential of biotechnology and biomanufacturing. Such governmental initiatives are set to create significant growth opportunities for the market over the forecast period of 2024-2030.
BioMEMS Market Drivers
Increasing penetration of wearable medical devices among the geriatric population to improve remote diagnostics and monitoring are impacting the market growth
Increasing penetration of mobile devices and wearable as a part of accelerating health condition monitoring including diabetes, blood pressure, blood gas monitoring and so on among the geriatric population acts as major factor driving the market growth towards global BioMEMS market. Growth in adoption of home care devices among consumers enabling remote diagnostics and monitoring is augmenting the market. Increasing integration of bioMEMS into such wearable and modules for mobile devices can be considered vital in boosting the market. The recent trend of shifting towards miniaturized systems using MEMS devices or MEMS technology is holding significant potential for growth in healthcare sector. The burgeoning demand for mobile care applications and patient monitoring equipment aids in the early diagnosis of disease indications, and such factors will propel the global BioMEMS market in healthcare sector. In Sep 2022, the development of BioMEMS's handheld, portable, in-vitro diagnostics platform aligns with the driver. The platform's capability to precisely measure biomarkers in various bio fluids, including saliva and urine, without the need for lab skills or intensive equipment supports remote diagnostics, making it suitable for applications like rapid disease testing and health monitoring outside traditional healthcare settings. This is set to fuel the market growth in the long run.
Growing integration of nanotechnology with Bio-MEMS supporting cellular interaction at molecular level drives its market forward
Growing integration of nanotechnology with Bio-MEMS supporting cellular interaction at molecular level act as a major driver boosting its market growth. In, nanotechnology integrated Bio-MEMS devices exhibits beneficiary capabilities such as low power consumption and lower production costs owing to its small size, which in turn are contributing towards the growth of the market Furthermore, with the substantial growth of medical field, biomedicine and bio-technology are evolving and adopting technological advancements. New developments in devices like accelerometers, drug delivery systems and gyroscopes or adoption of emerging technologies like DNA or microprotein arrays, enzyme-linked immuno-sorbent assay, and fluorescence resonance energy transfer-based analysis in medical field are the few factors boosting the market growth over time.
BioMEMS Market Challenges
High cost associated with extensive research & development and expensive upfront setup hinders its market growth
BioMEMS incurs high costs associated with its extensive R&D, installation, integration, deployment and additional maintenance services owing to its robust infrastructure combined with stringent security policies. Many medical equipment manufacturing and pharmaceutical companies are limiting its adoption due to high financial requirement. Traditional healthcare sector never had to invest in advanced technology thus many of them are still reluctant to adopt this technology due to limited budget allocation. Such factors have been creating an adverse impact on its market growth.
BioMEMS Industry Outlook
Product innovations, acquisitions, Partnerships and R&D activities are key strategies adopted by players in the market. BioMEMS top 10 companies include:
- Philips Engineering Solution
- Oxford Instruments
- Teledyne DALSA
- Taylor Hobson
- Abbott Laboratories
- IntelliSense Software
- LioniX International
- Biolinq
- SiMPore
- Precision Neuroscience
Recent Developments
- In Oct 2023, Precision Neuroscience achieved FDA breakthrough for its BCI, a significant BioMEMS market development. Acquiring a Texas MEMS foundry, it enhances production for the Layer 7 Cortical Interface with 1,024 electrodes. Aiming for 2024 FDA approval, Precision positions as a top U.S. biomedical MEMS manufacturer
- In Oct 2022, POSTECH unveiled a BioMEMS breakthrough: a skin-attachable intelligent microphone using polymer electrets and MEMS. This innovation improves voice detection in noisy settings, reducing dependence on conventional batteries. It marks a recent BioMEMS milestone, with applications in disaster response and healthcare, such as respiratory disease diagnosis and vocal cord monitoring.
For more Automation and Instrumentation related reports, please click here
1.1 Definitions and Scope
2. BioMEMS Market - Executive Summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key trends by End user
2.3 Key trends segmented by Geography
3. BioMEMS Market Landscape
3.1 Comparative Analysis
3.1.1 Product/Service Benchmarking-Top 5 Companies
3.1.2 Top 5 Financial Analysis
3.1.3 Market Value Split by Top 5 Companies
3.1.4 Patent Analysis
3.1.5 Pricing Analysis
4. BioMEMS Market – Startup Company Scenario
4.1 Investment
4.2 Revenue
4.3 Venture Capital Funding
5. BioMEMS Market – By Industry Market Entry Scenario Premium
5.1 Regulatory Framework
5.2 Customer Analysis
5.3 Case Studies
5.4 Ease of Doing Business Index
6. BioMEMS Market - Market Forces
6.1 Market Drivers
6.2 Market Constraints/Challenges
6.3 Porters five force model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Network of new entrants
6.3.4 Rivalry among existing players
6.3.5 Network of substitutes
7. BioMEMS Market – Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Product Life Cycle/Market Life Cycle Analysis
7.4 Vendors & Partners
8. BioMEMS Market – By Type (Market Size -$Million/Billion)
8.1 MEMS sensors
8.2 Micro fluid
8.3 Others
9. BioMEMS Market – By Material (Market Size -$Million/Billion)
9.1 Silicon and glass
9.2 Plastic and polymers
9.3 Paper
9.4 Biological material
10. BioMEMS Market – By Product (Market Size -$Million/Billion)
10.1 Injectables
10.2 Implantables
10.2.1 Stent
10.2.2 Gyroscope
10.2.3 Accelerometers
10.2.4 Biochips
10.2.5 Biosensors & drug delivery devices
10.2.6 Others
11. BioMEMS Market - By Application (Market Size -$Million/Billion)
11.1 Therapeutic
11.2 Tissue Engineering
11.3 Diagnostics
11.4 Others
12. BioMEMS Market - By End Users (Market Size -$Million/Billion)
12.1 Home Diagnostics
12.2 Healthcare
12.3 Pharmaceutical
12.4 Research center
12.5 Agriculture
12.6 Food
12.7 Others
13. BioMEMS Market – By Region (Market Size -$Million/Billion)
13.1 North America
13.1.1 U.S
13.1.2 Canada
13.1.3 Mexico
13.2 Europe
13.2.1 Germany
13.2.2 France
13.2.3 UK
13.2.4 Italy
13.2.5 Spain
13.2.6 Rest of Europe
13.3 APAC
13.3.1 China
13.3.2 Japan
13.3.3 South Korea
13.3.4 India
13.3.5 Australia
13.3.6 Rest of APAC
13.4 South America
13.4.1 Brazil
13.4.2 Argentina
13.4.3 Chile
13.4.4 Colombia
13.4.5 Rest of South America
13.5 RoW
13.5.1 Middle East
13.5.2 Africa
14. BioMEMS Market - Industry/Segment Competition Landscape
14.1 Company Benchmarking Matrix- Major Companies
14.2 Market Share at Global Level - Major companies
14.3 Market Share by Key Region - Major companies
14.4 Market Share by Key Country - Major companies
14.5 Market Share by Key Product Type/Product category - Major companies
15. BioMEMS Market - Key Companies List by Country
16. BioMEMS Market Entropy
16.1 New Product Launches
16.2 M&As, Collaborations, JVs and Partnerships
17. BioMEMS Market - Company Analysis - Business Overview, Product Portfolio, Financials, and Developments
17.1 Philips Engineering Solution
17.2 Oxford Instruments
17.3 Teledyne DALSA
17.4 Taylor Hobson
17.5 Abbott Laboratories
17.6 IntelliSense Software
17.7 LioniX International
17.8 Biolinq
17.9 SiMPore
17.10 Precision Neuroscience
"*Financials would be provided on a best-efforts basis for private companies"